Citation Impact
Citing Papers
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
2007 Standout
Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations
2010
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
2004 Standout
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
2005 StandoutScience
Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
2016
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial
2014
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
2009 StandoutNature
Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
1996
Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
1995
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.
1993
Thiazolidinediones
2004 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Early detection of undiagnosed diabetes mellitus: a US perspective
2000
Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
1996
Role of AMP-activated protein kinase in mechanism of metformin action
2001 Standout
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
2005 Standout
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
2011 Standout
The metabolic syndrome
2010 Standout
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Mechanism of Metformin Action in Obese and Lean Noninsulin-Dependent Diabetic Subjects*
1991
Marine natural products
1990 Standout
7 Insulin action and substrate competition
1993
Network medicine: a network-based approach to human disease
2010 Standout
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
2002 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Intracranial androgenic and estrogenic stimulation of male-typical behaviors in house mice (Mus domesticus)
1992
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
2003 Standout
The metabolic syndrome
2005 Standout
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
2014 StandoutNature
Type 2 diabetes
2017 Standout
Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial
2000 Standout
A graphene-based electrochemical device with thermoresponsive microneedles for diabetes monitoring and therapy
2016 Standout
Efficacy of Metformin in Type II Diabetes
1997
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Metformin Use and Mortality Among Patients With Diabetes and Atherothrombosis<alt-title>Metformin Use With Diabetes and Atherothrombosis</alt-title>
2010
Metformin
1996
Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM
1994
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Metformin reverses fatty liver disease in obese, leptin-deficient mice
2000
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
2007 Standout
Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study)
2001
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
2011 Standout
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
2006 Standout
Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight.
2000 Standout
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
1991 StandoutNature
The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways
2002
AMPK: a nutrient and energy sensor that maintains energy homeostasis
2012 Standout
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Continuous venovenous high-flux dialysis in multiorgan failure: A 5- year single-center experience
1998
Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
2002
Relationship between obesity, insulin resistance, and coronary heart disease risk
2002
Androgen Concentration in Motor Neurons of Cranial Nerves and Spinal Cord
1977 Science
The Effects of Metformin on Body Mass Index and Glucose Tolerance in Obese Adolescents With Fasting Hyperinsulinemia and a Family History of Type 2 Diabetes
2001
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Definition of Metabolic Syndrome
2004 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Effects of dihydrotestosterone on sexual behavior of castrated male rhesus monkeys
1974
Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes
2002
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Abolition of male sexual behaviors in mice lacking estrogen receptors α and β (αβERKO)
2000 StandoutNobel
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Unleash Metformin
2013
Evaluation of the Antiproliferative Activity of Diterpene Isonitriles from the SpongePseudoaxinella flavain Apoptosis-Sensitive and Apoptosis-Resistant Cancer Cell Lines
2011
Pharmacologic Therapy for Type 2 Diabetes Mellitus
1999
Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis
2003
The Role of Androgens in the Sexual Behavior of Adult Male Rhesus Monkeys
1974
Mechanisms of Diabetic Complications
2013 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome
2003
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
Mechanism by which metformin reduces glucose production in type 2 diabetes.
2000
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Works of P. Johnston being referenced
Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
1991
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
2009
Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
2009
Acute Changes in Plasma Non‐esterified Fatty Acid Concentration do not Change Hepatic Glucose Production in People with Type 2 Diabetes
1990
Intracerebral androgens and sexual behavior in the male rat
1972
Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM Patients
1990
Volumetric control of continuous haemodialysis in multiorgan failure.
1991
Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
1992